· AIM:Toinvestigatetheeffectsofposteriorscleral reinforcement (PSR)inthetreatmentofpathological myopia.
· METHODS:Thestudyincluded52eyesin43patients withpathologicalmyopiawhounderwentPSR(PSR group),and52eyesin36age-andmyopia-matched patientswhodidnotundergosuchtreatmentascontrol group.Axiallength,refractionerror,bestcorrectedvisual acuity(BCVA),andmacularscansbyopticalcoherence tomography (OCT)wererecordedatbaseline,6mo,1,3 and5yafterthesurgery,andthecomplicationswerenoted. [1] [2] [3] .Themostobvious characteristicofpathologicalmyopiaisthegradualgrowthof theaxiallength,whichisrapidduringchildhoodand adolescence,withfurther continualincreases inits dimensionsoccurringintheadultyearsoflife [4] .Excessive axialelongationoftheeyeswithpathologicalmyopiacan causescleralthinningandcreateshearingforceswithinthe contiguousstructures:thechoroid,theretinaandthevitreous body.Thefailureofthesetissueshasseriousimpactson macularfunctioningandcanalso leadtovarious complications,suchasmacularschisis,macularhole,retinal tearsanddetachment,whichmayresultinseverevisual impairmentinpathologicalmyopiceyes [4] [5] . However,thepathogenesisofpathologicalmyopiaisnot clearsofar.Geneticfactors,environmentalfactors,and life-stylefactorsmayplayaroletogetherinthecauseof pathologicalmyopia [6] [7] .Thereisnowidelyacceptedmedical or surgical treatmentthatcanpreventmyopicaxial elongationandmyopicprogressionasyet.Surgeonstriedto preventaxialelongationandstaphylomaprogressionby placinggraftsovertheposteriorpartoftheeyes.Posterior scleralreinforcement(PSR),whichwasfirstproposedby Shevelev [8] andwaslatermodifiedandsimplifiedby Thompson [9] ,hasthepotentialtopreventtheprogressionof pathologicalmyopia.Afteryearsofexperiencewiththeir ownvariationsofscleralreinforcement,Thompsonandother scholarsexpressedsatisfactionwiththeefficacyandsafetyof theirseriesofcases [10] [11] [12] [13] [14] [15] .Incontrast,Karabatsas [16] and ZhangandWu [17] hadnegativeconclusionsontheoutcomes forthereinforcementsurgery.Therefore,PSRisconsidered [19] [20] .PSRisbelievedtoslowtheaxialelongation bythedirectmechanicalforceofthereinforcementband surroundingtheposteriorpoleand/orbythesclera remodelingandhyperplasiasecondarytothenon-specific inflammatoryreactionbetweentheposteriorscleraandthe reinforcementband.PSRmaybetheonlyeffectivemethod thatcandelayorstoptheaxialelongationinpathological myopiauptodate [14] . [18] andJi [22] . TheyreportedthatPSRalonemaybeusefulfortreating myopicmacularschisisforstrengtheningthemacular structureandhelpingtomaintainBCVA.Thoughvitrectomy andpre-retinalmembranepeelingreleasedmyopicmacular schisis [23] [24] [25] ,PSRhasbeensuggestedasatreatmentoptionfor myopicmacularschisis.PSRcanavoidfurtherintraocular surgery,withtheadditionalbenefitsofpreventingaxial elongationandmyopiaprogression. IthasbeenreportedthatPSRmayleadtosomeserious complicationssuchasretinaldetachmentandcilioretinal arteryocclusion [16] [17] .Theabsenceofanyvision-threatening complicationswasapositiveoutcomeofourpresentstudy. The most commoncomplicationsweretemporary: congestionandedemaoftheconjunctiva,increaseofIOP, weaknessof ocular movementand slight diplopia. Pre-operativecounsellingallowedthepatientstobeprepared foranuncertainperiodofweaknessofocularmovementand slightdiplopia,andcreatedawarenessoftheneedfora periodoftopicalmedicationforIOPcontrol.Noserious complicationsoccurredduringthe5-yearfollow-upperiodin ourstudy. Inconclusion,ourfindingssuggestedthatPSRcanprevent theaxialelongationandmyopiaprogressionineyeswith pathologicalmyopia.Furtherstudiesareneededtodetermine thelong-termsafetyandeffectivenessofthissurgery.
